Ausgabe 4/2015
Inhalt (29 Artikel)
The Canadian Choosing Wisely campaign: the Canadian Hematology Society’s top five tests and treatments
Christopher M. Hillis, Aaron D. Schimmer, Stephen Couban, Mark A. Crowther
Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients—an evidence-based approach
Meinolf Karthaus, Thomas Lehrnbecher, Hans-Peter Lipp, Stefan Kluge, Dieter Buchheidt
Two cycles of risk-adapted consolidation therapy in patients with acute promyelocytic leukemia. Results from the SAL-AIDA2000 trial
Christoph Röllig, Kerstin Schäfer-Eckardt, Matthias Hänel, Michael Kramer, Markus Schaich, Christian Thiede, Uta Oelschlägel, Brigitte Mohr, Thomas Wagner, Hermann Einsele, Stefan W. Krause, Heinrich Bodenstein, Sonja Martin, Reingard Stuhlmann, Antony D. Ho, Martin Bornhäuser, Gerhard Ehninger, Ulrich Schuler, Uwe Platzbecker
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Patricia Font, Javier Loscertales, Carlos Soto, Pilar Ricard, Carolina Muñoz- Novas, Estela Martín-Clavero, Montserrat López-Rubio, Luis Garcia-Alonso, Marta Callejas, Alfredo Bermejo, Celina Benavente, Mónica Ballesteros, Teresa Cedena, María Calbacho, Raquel Urbina, Jesús Villarrubia, Santiago Gil, José María Bellón, José Luis Diez-Martin, Ana Villegas
Long-term outcomes of first-line treatment with doxycycline in patients with previously untreated ocular adnexal marginal zone B cell lymphoma
Jae Joon Han, Tae Min Kim, Yoon Kyung Jeon, Mee Kum Kim, Sang In Khwarg, Chul-Woo Kim, Il Han Kim, Dae Seog Heo
Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with l-asparaginase-containing chemotherapy—a single institution experience
Jian Zang, Chen Li, Shan-Quan Luo, Jian-Hua Wang, Man Xu, Li-Na Zhao, Wei-Wei Li, Hua Yang, Feng Xiao, Ying J. Hitchcock, Mei Shi
Non-pegylated liposomal doxorubicin in lymphoma: patterns of toxicity and outcome in a large observational trial
Ines Wasle, Gabriele Gamerith, Florian Kocher, Patrizia Mondello, Thomas Jaeger, Alois Walder, Jutta Auberger, Thomas Melchardt, Werner Linkesch, Michael Fiegl, Michael Mian
Serum hepcidin-25 level linked with high mortality in patients with non-Hodgkin lymphoma
Masaki Hara, Minoru Ando, Ken Tsuchiya, Kosaku Nitta
Extranodal and nodal diffuse large B cell lymphoma of the head and neck: two different entities?
L. A. Guardado Sánchez, A. M. Redondo, O. Blanco Muñez, E. Sebastián, M. Alcoceba, M. González, A. Martín, D. Caballero
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation
Seong Hyun Jeong, Joon Ho Moon, Jin Seok Kim, Deok-Hwan Yang, Yong Park, Seok Goo Cho, Jae-Yong Kwak, Hyeon Seok Eom, Jong Ho Won, Jun Shik Hong, Sung Yong Oh, Ho Sup Lee, Seok Jin Kim
Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 109/L monoclonal lymphocytes better identifies subgroups with different outcomes
A. C. Oliveira, A. Fernández de Sevilla, A. Domingo, E. De La Banda, E. Domingo-Domènech, S. Mercadal, N. Ruiz-Xivillé, E. Alonso, M. Encuentra, E. González-Barca
Results of a phase II study of bendamustine and ofatumumab in untreated indolent B cell non-Hodgkin’s lymphoma
Myron S. Czuczman, Stephen Kahanic, Andres Forero, Glen Davis, Mihaela Munteanu, Eric Van Den Neste, Fritz Offner, Dominique Bron, Donald Quick, Nathan Fowler
Bendamustine in combination with thalidomide and dexamethasone is a viable salvage option in myeloma relapsed and/or refractory to bortezomib and lenalidomide
I-Jun Lau, Dean Smith, Robin Aitchison, Norbert Blesing, Pamela Roberts, Andrew Peniket, Kwee Yong, Neil Rabin, Karthik Ramasamy
Elderly multiple myeloma patients experience less deterioration in health-related quality of life than younger patients compared to a normative population: a study from the population-based PROFILES registry
M. W. M. van der Poel, S. Oerlemans, H. C. Schouten, L. V. van de Poll-Franse
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation
Eolia Brissot, Xavier Cahu, Thierry Guillaume, Jacques Delaunay, Sameh Ayari, Pierre Peterlin, Amandine Le Bourgeois, Jean-Luc Harousseau, Noel Milpied, Marie-Christine Bene, Philippe Moreau, Mohamad Mohty, Patrice Chevallier
L-carnitine effectively improves the metabolism and quality of platelet concentrates during storage
Mohammad Reza Deyhim, Seyed Alireza Mesbah-Namin, Fatemeh Yari, Mohammad Taghikhani, Naser Amirizadeh
The immunoglobulin isotype matters in diffuse-large-B-cell lymphoma with serum paraproteinaemia
M. Christina Cox, Arianna Di Napoli, Stefania Scarpino, Luigi Ruco
Paraneoplastic pemphigus occurring after bendamustine and rituximab therapy for relapsed follicular lymphoma
Takashi Higo, Tomomitsu Miyagaki, Fumihiko Nakamura, Akihito Shinohara, Hiroki Asano, Hiroyuki Abe, Naoyuki Senda, Ayumi Yoshizaki, Masashi Fukayama, Mineo Kurokawa
Intravenous bortezomib for multiple myeloma that has progressed after subcutaneous bortezomib therapy
Junya Kuroda, Shinsuke Mizutani, Yuji Shimura, Saori Maegawa, Hisao Nagoshi, Yoshiaki Chinen, Shotaro Tatekawa, Taku Tsukamoto, Yoshimi Mizuno, Mio Yamamoto-Sugitani, Tsutomu Kobayashi, Yosuke Matsumoto, Shigeo Horiike, Masafumi Taniwaki
Cutaneous presentation of an aggressive plasmablastic neoplasm indiscriminate between lymphoma and myeloma
Alice C. Johnston, Kikkeri Naresh, Tara Barwick, Philippa May, Anastasios Karadimitris, Holger W. Auner
Molecular analysis of loss of CCR4 expression during mogamulizumab monotherapy in an adult T cell leukemia/lymphoma patient
Masataka Taguchi, Yoshitaka Imaizumi, Daisuke Sasaki, Tomonori Higuchi, Kazuto Tsuruda, Hiroo Hasegawa, Jun Taguchi, Yasushi Sawayama, Daisuke Imanishi, Tomoko Hata, Katsunori Yanagihara, Osamu Yoshie, Yasushi Miyazaki
Cutaneous Langerhans cell sarcoma relapsing systemically: Complete remission with the EPIG regimen
Yok-Lam Kwong
Severe haemophagocytic lymphohistiocytosis triggered by a visceral leishmaniasis in a patient with a Rosai-Dorfman disease
Thibault Comont, Guillaume Martin-Blondel, Camille Laurent, Antoine Berry, Bruno Marchou
Unilateral hearing loss due to lymphocytosis and a contralateral putamen lesion
Hilda Wong, Yu-Yan Hwang, Rock Y. Y. Leung, Gavin S. W. Chan, Pek-Lan Khong, Yok-Lam Kwong
Quality assessment of autologous haematopoietic blood progenitor cell grafting
Francesco Lanza, Sandro Dallorso, Giuseppe Milone, Pierangelo Spedini, Clara Viganò, Hans Johnsen
The first two cases of MYH9 disorders in Thailand: an international collaborative study
Nongnuch Sirachainan, Patcharee Komwilaisak, Katsumasa Kitamura, Suradej Hongeng, Takashi Sekine, Shinji Kunishima
Safety and efficacy of ruxolitinib in a profoundly thrombocytopenic patient with myelofibrosis
C. Armstrong, S. W. Maung, P. Neary, J. McHugh, H. Enright
Activated partial thromboplastin time sensitivity to lupus anticoagulant in a patient with transient arthritis and lupus anticoagulant-hypoprothrombinemia syndrome
Laetitia Mauge, Amélie Passeron, Martine Alhenc-Gelas, Jacques Pouchot, Luc Darnige
Erlotinib is not effective in patients with JAK2V617F-positive polycythemia vera
Mohamad Cherry, Mohamad Khawandanah, Zhizhuang Joe Zhao, Samer Srour, Howard Ozer, George Selby, Bassam Ghabache, Aref Al-Kali